2022-11-25 05:49:18

Carbapenem-Based Antibiotics Market to Grow at a CAGR of 4.4% during 2021-2028

Logo EIN Presswire
EIN Presswire

Pfizer, Inc. And Merck & Co., Inc - Notable Market Players in Carbapenem-based Antibiotics Market

NEW YORK, UNITED STATES, November 25, 2022 /EINPresswire.com/ -- Antibiotics that have base of carbapenems are type of atypical -lactam antibiotics that have broader antibacterial activities. These antibiotics can act against many gram-positive, gram-negative aerobic, anaerobic bacteria. Additionally, these antibiotics are stable to most -lactamases and hence, are indicated as empiric monotherapy for various serious conditions such as neutropenic infections and intra-abdominal infections.

The carbapenem based antibiotics market size is projected to reach US$ 5,346.62 million by 2028 from US$ 3,964.57 million in 2021; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028. The report highlights the key factors and trends impacting the carbapenem based antibiotics market and focuses on prominent players and their game-changing strategies.

Get Sample PDF Copy of this Report: https://www.theinsightpartners.com/sample/TIPRE00027228/

The rising prevalence of gram-negative bacterial infections and the increasing production of generics drugs drive the market growth. However, the tedious and expensive process for the development of antibiotics hampers the market growth.

Leading companies operating in the market have undertaken various organic growth strategies in the market. The carbapenem-based antibiotics market is majorly comminated by GlaxoSmithKline Pfizer Inc.; Savior Lifetec; Sumitomo Dainippon Pharma Co., Ltd.; Merck & Co., Inc.; Gland Pharma Limited; Aurobindo Pharma Ltd; Daewoong Pharmaceutical Co.,Ltd; Iterum Therapeutics plc; ACS Dobfar S.p.A, and Spero Therapeutics amongst others. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the market players have also deployed several utilized inorganic strategies, including mergers & acquisitions, partnerships, and collaborations.

Below are the major growth strategies undertaken by the players operating in the global carbapenem-based antibiotics market:

In January 2022, Spero Therapeutics received Priority Review designation by the U.S. Food and Drug Administration (FDA) and confirmed the acceptance for substantive review of the New Drug Application (NDA) seeking approval for tebipenem HBr oral tablets for treatment in adult patients with complicated urinary tract infections (cUTI), including acute pyelonephritis, caused by susceptible microorganisms.

In September 2021, Iterum Therapeutics plc announced that the Company held a Type A meeting with the U.S. Food and Drug Administration (FDA) during the third quarter of 2021 to talk about the steps required for potential resubmission of the New Drug Application (NDA) for sulopenem etzadroxil/probenecid (oral sulopenem) for the treatment of uncomplicated urinary tract infections (uUTI). Later in July, the company received a Complete Response Letter (CRL) from the FDA requesting additional data to support approval of oral sulopenem for the treatment of adult women with a uUTI.

In February 2022, Sumitomo Dainippon Pharma Co., Ltd entered partnership with its parent company Sumitomo Dainippon Pharma Co., Ltd to launch phase 1 study in the U.S. on a new drug candidate ("KSP-1007") for carbapenem-resistant bacterial infections. The launch was a result of a joint research project between Sumitomo Dainippon Pharma and the Kitasato Institute in Japan.

In July 2020, Pfizer Inc. announced its pledge to invest USD 100 million to the new Antimicrobial Resistance (AMR) Action Fund, launched by the company to help address the significant global public health need for new antibiotics due to the rapid rise of antibiotic-resistant infections.

Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPRE00027228/

About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, chemicals etc.

Contact Us:

Sameer Joshi
The Insight Partners
+91 96661 11581
email us here
Visit us on social media:

Continue read on einpresswire.com

Logo EIN Presswire
HealthPress Release2022-11-16 19:48:13
Antibiotics Market antibiotics market is estimated to garner a notable revenue by the end of 2033 by growing at a CAGR of ~8% over the forecast period, i.e.,...

Logo EIN Presswire
HealthPress Release2022-11-04 13:00:00
Market Research Reports, Business Consulting Services & Analytics Heightening Applications Of Cephalosporins Are Expected To Boost The Demand Of...

Logo Benzinga
Business / FinanceBy Pr Newswire2022-11-03 10:10:00
Antibacterial drugs market size pegged at US$ 46.37 Bn in 2018; R&D on novel unexploited targets and approaches in combating multi-drug resistant strains...

Logo PR Newswire
HealthPress Release2022-11-03 10:10:00
Antibacterial drugs market size pegged at US$ 46.37 Bn in 2018; R&D on novel unexploited targets and approaches in combating multi-drug resistant strains...

Logo PR Newswire
NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Trends, opportunities, and forecast for antimicrobial active ingredients in the global personal care market in 2027...

Logo EIN Presswire
Market Research Reports, Business Consulting Services & Analytics Rapid urbanization and infrastructural developments in emerging economies are...

Logo EIN Presswire
Diethyltoluamide Market Share 2022 The global diethyltoluamide market is projected to grow at a compound annual growth rate (CAGR) of 3.5% NEW YORK CITY, NEW...

Logo EIN Presswire
Carob Gum Market Carob Gum Market Segmented By Analysis, CAGR, Regions, Manufacturers, Types, and Applications Forecast 2022-2030 NEW YORK CITY, NY 10170.,...

Logo EIN Presswire
HealthPress Release2022-11-01 09:48:29
Market Research Reports, Business Consulting Services & Analytics Treatment Of Antibiotic Resistance, Which is Driving The Growth Of The Antibiotic...

Logo EIN Presswire
Pharma Microbiology Testing Kits Global Market Report 2022 : Market Size, Trends, And Forecast To 2026 Pharma Microbiology Testing Kits Global Market Report...

Logo EIN Presswire
Carboplatin Crystal Market Share 2022 Carboplatin Crystal Market By Global Industry Trends, Future Growth, Regional Overview, Size, Share Estimation,...

Logo GlobeNewswire
EconomyPress Release2022-11-16 16:19:00
Increase in demand for convenience foods, rise in demand for natural food preservatives, and the growing consumption of ready-to-eat food products due to...

Logo EIN Presswire
SHERIDAN, WY, UNITED STATES, November 21, 2022 / EINPresswire.com / -- The latest report by IMARC Group, titled Bio-Polyamide Market: Global Industry Trends,...

Logo EIN Presswire
The growing popularity of probiotic dietary supplements among consumers has fueled the market's expansion for nutraceutical ingredients. PORTLAND, OR, US,...

Logo PR Newswire
HealthPress Release2022-11-24 15:30:00
NOIDA, India, Nov. 24, 2022 /PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Human Microbiome Market was valued at more...

Logo EIN Presswire
Veterinary Antibiotics Market 2022 – Opportunities And Strategies – Global Forecast To 2030 The Business Research Companys Veterinary Antibiotics Market 2022...

Logo PR Newswire
HealthPress Release2022-11-18 09:00:00
NEW YORK, Nov. 18, 2022 /PRNewswire/ -- The probiotic dietary supplements market size is expected to grow by USD 1.50 billion from 2021 to 2026. In addition,...

Logo EIN Presswire
HealthPress Release2022-11-11 19:48:22
Probiotics is the introduction of microorganisms in/on the host body for its beneficial qualities. NEWARK, UNITED STATES, November 11, 2022 /...

Logo EIN Presswire
HealthPress Release2022-11-23 12:11:17
Oral Biologics Market Biological drugs are widely used in the treatment of number of diseases including diabetes, plaque psoriasis, arthritis, Crohns disease...